PRESS RELEASE published on 07/13/2023 at 10:11, 2 years 4 months ago Baader Bank AG: Dietmar von Blücher stepping down from the Board of Directors and leaving the company at his own request
PRESS RELEASE published on 07/07/2023 at 07:31, 2 years 4 months ago Baader Bank Annual General Meeting elects new Supervisory Board
PRESS RELEASE published on 06/16/2023 at 13:23, 2 years 5 months ago Industry meeting for asset managers and neobrokers at Baader Bank
PRESS RELEASE published on 04/27/2023 at 07:30, 2 years 7 months ago Baader Bank posts positive consolidated pre-tax result and continued growth for Q1 2023
PRESS RELEASE published on 03/31/2023 at 17:32, 2 years 8 months ago Baader Bank closes successful 2022 financial year and shares 2023 outlook
PRESS RELEASE published on 02/10/2023 at 07:30, 2 years 9 months ago Baader Bank accelerates growth and closes successful 2022 financial year
PRESS RELEASE published on 01/16/2023 at 14:00, 2 years 10 months ago Baader Helvea Swiss Equities Conference sees a large attendance on its return to being a physical event
Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 29 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 9 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 34 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 49 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
